Incorporating Novelty and Diversity in Oncology Drug Discovery: From Cancer Genome Screening to Ligand Identification
Time: 10:45 am
day: Day Two
Details:
• Focusing on unique, ‘yet to be drugged’ cancer targets
• Enabling novel targets for screening campaigns to interrogate ligandability
• Evaluating hits identified from orthogonal screening methods
